KLRD1 and Miyoshi myopathy: IL-12 alone or in combination with IL-18 does not have any significant (p > 0.05, Wilcoxon signed rank test) effect on the expression of this NK cell receptor on NK cells, as well as on their subsets in HC and in MM patients (Figure 4a).